Evidence of physical ability to perform the requested privilege. Data from professional practice review by an organization(s) that currently privileges the applicant (if available). Peer and/or faculty recommendation. When renewing privileges, review of the practitionerâs performance within the hospital.
Janssen, however, also marketed Risperdal as a treatment for older people with agitation from dementia, which is not an FDA-approved use of the medication. In fact, it can be dangerous for older adults with dementia to take antipsychotics, including Risperdal, and Janssen had to pay a fine for misbranding the drug.
Johnson & Johnsonâs antipsychotic drug Risperdal is a potent prescription medication thatâs widely prescribed for adults, adolescents and children for both approved and unapproved uses. The drug carries several risks, and its label includes a black box warning, the strongest drug warning in the U.S.